Related references
Note: Only part of the references are listed.Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign
Reginald E. Greene et al.
CLINICAL INFECTIOUS DISEASES (2007)
Posaconazole as salvage therapy for zygomycosis
RN Greenberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Invasive pulmonary aspergillosis: frequency and meaning of the hypodense sign on unenhanced CT
M Horger et al.
BRITISH JOURNAL OF RADIOLOGY (2005)
Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer
G Chamilos et al.
CLINICAL INFECTIOUS DISEASES (2005)
Reversed halo sign in pulmonary paracoccidioidomycosis
EL Gasparetto et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2005)
Zygomycosis in a Tertiary-Care Cancer Center in the era of Aspergillus-active antifungal therapy:: A case-control observational study of 27 recent cases
DP Kontoyiannis et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Fusarium infections in critically Ill patients
MS Lionakis et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: Diagnostic implications
SJ Kim et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2003)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
S Ascioglu et al.
CLINICAL INFECTIOUS DISEASES (2002)
Burden of aspergillosis-related hospitalizations in the United States
EJ Dasbach et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
